Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.987-996, 2005. ,
DOI : 10.1056/NEJMoa043330
Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide, Radiotherapy and Oncology, vol.97, issue.3, pp.377-381, 2010. ,
DOI : 10.1016/j.radonc.2010.08.020
A Phase I Dose Escalation Study of Hypofractionated IMRT Field-in-Field Boost for Newly Diagnosed Glioblastoma Multiforme, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.2, pp.743-748, 2012. ,
DOI : 10.1016/j.ijrobp.2010.10.018
Intensity-modulated radiation therapy in newly diagnosed glioblastoma: A systematic review on clinical and technical issues, Radiotherapy and Oncology, vol.97, issue.3, pp.361-369, 2010. ,
DOI : 10.1016/j.radonc.2010.08.018
Survival and Failure Patterns of High-Grade Gliomas After Three-Dimensional Conformal Radiotherapy, Journal of Clinical Oncology, vol.20, issue.6, pp.1635-1642, 2002. ,
DOI : 10.1200/JCO.2002.20.6.1635
Rosen I: 201Thallium SPECT and 1H-MRS compared with MRI in chemotherapy monitoring of high-grade malignant astrocytomas, Journal of Neuro-Oncology, vol.46, issue.2, pp.173-185, 2000. ,
DOI : 10.1023/A:1006429329677
Concurrent Temozolomide and Dose-Escalated Intensity-Modulated Radiation Therapy in Newly Diagnosed Glioblastoma, Clinical Cancer Research, vol.18, issue.1, pp.273-279, 2012. ,
DOI : 10.1158/1078-0432.CCR-11-2073
Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET., Radiology, vol.177, issue.3, pp.633-641, 1990. ,
DOI : 10.1148/radiology.177.3.2243962
Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens, AJNR Am J Neuroradiol, vol.22, pp.604-612, 2001. ,
Proton magnetic resonance spectroscopic imaging as a cancer biomarker for pediatric brain tumors (Review), international Journal of Oncology, vol.32, issue.3, pp.517-526, 2008. ,
DOI : 10.3892/ijo_32_3_517
Noninvasive Magnetic Resonance Spectroscopic Imaging Biomarkers to Predict the Clinical Grade of Pediatric Brain Tumors, Clinical Cancer Research, vol.10, issue.24, pp.8220-8228, 2004. ,
DOI : 10.1158/1078-0432.CCR-04-0603
3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI, International Journal of Radiation Oncology*Biology*Physics, vol.59, issue.1, pp.126-137, 2004. ,
DOI : 10.1016/j.ijrobp.2003.08.023
Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM, Journal of Neuro-Oncology, vol.1, issue.3, pp.337-351, 2009. ,
DOI : 10.1007/s11060-008-9719-x
Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy, Journal of Neuro-Oncology, vol.71, issue.1, pp.69-81, 2009. ,
DOI : 10.1007/s11060-008-9685-3
Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma, Journal of Neuro-Oncology, vol.61, issue.1, pp.63-76, 2008. ,
DOI : 10.1007/s11060-008-9632-3
Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence, Journal of Neurosurgery, vol.97, issue.4, pp.794-802, 2002. ,
DOI : 10.3171/jns.2002.97.4.0794
Patterns of Recurrence Analysis in Newly Diagnosed Glioblastoma Multiforme After Three-Dimensional Conformal Radiation Therapy With Respect to Pre???Radiation Therapy Magnetic Resonance Spectroscopic Findings, International Journal of Radiation Oncology*Biology*Physics, vol.69, issue.2, pp.381-389, 2007. ,
DOI : 10.1016/j.ijrobp.2007.03.019
Distinction Between Recurrent Glioma and Radiation Injury Using Magnetic Resonance Spectroscopy in Combination With Diffusion-Weighted Imaging, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.1, pp.151-158, 2007. ,
DOI : 10.1016/j.ijrobp.2006.12.001
Phase I Trial of Tipifarnib (R115777) Concurrent With Radiotherapy in Patients with Glioblastoma Multiforme, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.5, pp.1396-1401, 2007. ,
DOI : 10.1016/j.ijrobp.2007.02.043
Proton Magnetic Resonance Spectroscopic Imaging in Newly Diagnosed Glioblastoma: Predictive Value for the Site of Postradiotherapy Relapse in a Prospective Longitudinal Study, International Journal of Radiation Oncology*Biology*Physics, vol.70, issue.3, pp.773-781, 2008. ,
DOI : 10.1016/j.ijrobp.2007.10.039
Molecular Imaging???Based Dose Painting: A Novel Paradigm for Radiation Therapy Prescription, Seminars in Radiation Oncology, vol.21, issue.2, pp.101-110, 2011. ,
DOI : 10.1016/j.semradonc.2010.10.001
Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: Practical implications of using a broad or sharp brush, Radiotherapy and Oncology, vol.100, issue.3, pp.396-401, 2011. ,
DOI : 10.1016/j.radonc.2011.08.048
Evaluation of Four Volume-Based Image Registration Algorithms, Medical Dosimetry, vol.34, issue.4, pp.317-322, 2009. ,
DOI : 10.1016/j.meddos.2008.12.004
Estimation of Radiobiologic Parameters and Equivalent Radiation Dose of Cytotoxic Chemotherapy in Malignant Glioma, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.2, pp.441-448, 2007. ,
DOI : 10.1016/j.ijrobp.2006.12.025
Quantifying the degree of conformity in radiosurgery treatment planning, International Journal of Radiation Oncology*Biology*Physics, vol.55, issue.5, pp.1409-1419, 2003. ,
DOI : 10.1016/S0360-3016(02)04599-6
Color gamut tranform pairs, SIGGRAPH 78 Conference Proceedings, pp.12-19, 1978. ,
DOI : 10.1145/800248.807361
Integrated-Boost-IMRT mit FET-PET-adaptierter lokaler Dosiseskalation beim Glioblastom, Strahlentherapie und Onkologie, vol.25, issue.4, pp.334-339, 2012. ,
DOI : 10.1007/s00066-011-0060-5
A Phase I Dose-Escalation Study (ISIDE-BT-1) of Accelerated IMRT With Temozolomide in Patients With Glioblastoma, International Journal of Radiation Oncology*Biology*Physics, vol.77, issue.1 ,
DOI : 10.1016/j.ijrobp.2009.04.064
High-dose radiotherapy to 78??Gy with or without temozolomide for high grade gliomas, Journal of Neuro-Oncology, vol.359, issue.suppl 1, pp.343-348, 2009. ,
DOI : 10.1007/s11060-008-9779-y
A pilot study of hypofractionated radiation therapy with temozolomide for adults with glioblastoma multiforme, Journal of Neuro-Oncology, vol.21, issue.2, pp.247-253, 2011. ,
DOI : 10.1007/s11060-010-0306-6
Use of MR spectroscopy and functional imaging in the treatment planning of gliomas, The British Journal of Radiology, vol.80, issue.953, pp.347-354, 2007. ,
DOI : 10.1259/bjr/65349468
Magnetic resonance spectroscopy imaging (MRSI) and brain functional magnetic resonance imaging (FMRI) for radiotherapy treatment planning of glioma, Technol Cancer Res Treat, vol.7, pp.349-362, 2008. ,
Integration of biochemical images of a tumor into frameless stereotaxy achieved using a magnetic resonance imaging/magnetic resonance spectroscopy hybrid data set, Journal of Neurosurgery, vol.101, issue.2, pp.287-294, 2004. ,
DOI : 10.3171/jns.2004.101.2.0287
Radiotherapy of malignant gliomas: Comparison of volumetric single arc technique (RapidArc), dynamic intensity-modulated technique and 3D conformal technique, Radiotherapy and Oncology, vol.93, issue.3, pp.593-596, 2009. ,
DOI : 10.1016/j.radonc.2009.10.002
Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up, The Lancet Neurology, vol.8, issue.9, pp.810-818, 2009. ,
DOI : 10.1016/S1474-4422(09)70204-2